" class="no-js "lang="en-US"> Nadhim Zahawi - Medtech Alert
Monday, January 20, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Nadhim Zahawi

Nadhim Zahawi

About Nadhim Zahawi

Nadhim Zahawi was appointed as Parliamentary Under Secretary of State at the Department for Business, Energy and Industrial Strategy on 26 July 2019.

He was also appointed as a Parliamentary Under Secretary of State at the Department of Health and Social Care on 28 November 2020.

He was previously Parliamentary Under Secretary of State at the Department for Education from 9 January 2018 to 26 July 2019.

Nadhim was elected as Conservative MP for Stratford-on-Avon in May 2010.

Related Story

COVID-19

 England to Return to Plan A Following the Success of the Booster Programme | Pharmtech Focus

England to Return to Plan A Following the Success of the Booster Programme

January 21 2022

The government has today announced that England will fully return to Plan A on Thursday […]

COVID-19

 Testing Measures to Ensure Young People Return to Classrooms | Pharmtech Focus

Testing Measures to Ensure Young People Return to Classrooms

January 4 2022

All secondary schools have been asked to provide one on-site test for pupils ahead of […]

COVID-19

 Nightlife Industry Joins Covid-19 Vaccine Push for Young People | Pharmtech Focus

Nightlife Industry Joins Covid-19 Vaccine Push for Young People

August 6 2021

Leading figures of the nightlife industry – including venues Ministry of Sound and Heaven – […]

COVID-19

 Almost 100% of People Have Antibodies After Second Vaccine | Pharmtech Focus

Almost 100% of People Have Antibodies After Second Vaccine

July 16 2021

Imperial College London and Ipsos MORI have today published their latest antibody surveillance report showing, […]

COVID-19

 Leading Social Media Platforms Unite to Support COVID-19 Vaccine Drive | Pharmtech Focus

Leading Social Media Platforms Unite to Support COVID-19 Vaccine Drive

June 21 2021

Collaboration comes as all adults aged 18 and over invited to get a jab Filters […]

COVID-19

 More than 30 Million People Vaccinated with Second Dose | Pharmtech Focus

More than 30 Million People Vaccinated with Second Dose

June 16 2021

More than 30 million people in the UK have been vaccinated with a second dose […]

COVID-19

 Janssen single dose Covid-19 vaccine authorised by UK medicines regulator | Pharmtech Focus

Janssen single dose Covid-19 vaccine authorised by UK medicines regulator

June 1 2021

Janssen’s single-dose COVID-19 vaccine has been authorised for use by the UK medicines regulator. The […]

COVID-19

 60 Million Doses of Covid-19 Vaccine Administered in UK | Pharmtech Focus

60 Million Doses of Covid-19 Vaccine Administered in UK

May 23 2021

Around 72% of UK adults have received a first dose of a COVID-19 vaccine, the […]

Clinical Trials

 World-first Covid-19 Vaccine Booster Study Launches in UK | Pharmtech Focus

World-first Covid-19 Vaccine Booster Study Launches in UK

May 20 2021

Thousands of volunteers will receive a booster COVID-19 vaccine in a new clinical trial launching […]